Accelerating medical innovations
for commercial readiness
ECHELON Med Tech develops and commercializes dual-use medical technologies to radically improve health outcomes for warfighters, veterans and civilians.
We partner with leading innovators in medical device research to create solutions for major health problems that are being faced on the battlefield and on Main Street.
Technology Candidates
We analyze the market need for innovative solutions, IP strength, grant history and potential, and 25 other criteria in our proprietary technology assessment model. We also carefully consider the likelihood of commercialization success given the specific experience of our management team. Ideal candidates are at a minimum Technology Readiness Level (TRL) of 3 or 4.
TRL
03
Hypothesis testing and initial proof-of-concept demonstrated in a limited number of laboratory, in vitro, and in vivo models.
TRL
04
Proof-of-concept and safety of devices and systems are demonstrated in defined laboratory and animal models.
Advancing healthcare technology for
service members and civilians
How does our model drive
investor value?
The deep military, scientific, commercialization and
investment experience of the ECHELON team makes
us a valuable technology developer for partnering
with or acquisition by strategic market leaders.
01
License Innovations
Sensor and device technology that solves unmet service member and civilian health needs
02
Develop and
De-Risk
De-risk and demonstrate the commercial value proposition through Voice of Customer research, FDA clearance and manufacturing scale-up
03
Market Opportunities
Department of Defense and civilian markets
04
Commercialization Options
Based on prior experience and market opportunity, build out ECHELON to launch or license/sell asset to strategic partner
05
Exit Strategy
With several assets, ECHELON model delivers investors multiple “bites of the apple” for favorable returns
Contact Us
Have an investor or investigator question? Fill out the form, and the ECHELON team will be in touch as soon as possible.